Evidence map›Paper›PMID 9032332›Full record

ArticleJournal of virology1997

Distinct domains of adenovirus E1A interact with specific cellular factors to differentially modulate human immunodeficiency virus transcription.

S F Parker, L K Felzien, N D Perkins, M J Imperiale, G J Nabel

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Role of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alpha.Proceedings of the National Academy of Sciences of the United States of America · 2002
    Article
  5. Review
  6. Article
  7. Article
  8. HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator.Proceedings of the National Academy of Sciences of the United States of America · 1998
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

S F ParkerDepartment of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0650, USA.
L K Felzien
N D Perkins
M J Imperiale
G J Nabel
University of Michigan · US

Funding

DEFINITION AND REGULATION OF CELLULAR GENESR01AI029179 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NABEL, GARY J · 1989 to 1993
–
NIAID NIH HHS R01 AI29179
6 · The paper itself

Abstract

Transcription of human immunodeficiency virus (HIV) type 1 and other viruses is regulated by the transcription factor NF-kappaB, which interacts with the multifunctional cellular protein p300. p300, originally identified by its ability to bind adenovirus early region 1A (E1A), has also been shown to regulate HIV transcription through its interaction with NF-kappaB. The 13S form of E1A activates HIV gene expression, while the 12S form represses its transcription. In this report, we have investigated whether these divergent effects of E1A are dependent upon common or distinct cellular cofactors, including p300, pRb, and the TATA box-binding protein (TBP). Unlike activation in the absence of E1A, cooperative stimulation of HIV gene expression by 13S E1A and RelA was independent of the ability of E1A to bind p300 but was critically dependent on the E1A CR3 region which associates with TBP. In contrast, inhibition of basal HIV gene expression by the 12S form of E1A was dependent on p300 but not pRb or TBP. Interestingly, mutation of the CR2 region of 12S E1A responsible for pRb binding abolished the repression of HIV transcription stimulated by tumor necrosis factor alpha, suggesting that repression of cytokine-activated transcription involves cofactors different from those used in unstimulated cells. Repression and activation of HIV transcription by different forms of E1A are mediated by distinct sets of cellular cofactors. These findings suggest that E1A has evolved to interact by alternative mechanisms with a transcriptional coactivator and its associated cofactors to differentially modulate cellular and viral gene expression.

Indexed as

HIV Long Terminal RepeatTrans-ActivatorsTranscriptional ActivationAdenovirus E1A ProteinsBinding SitesCell LineDNA-Binding ProteinsGene Expression Regulation, ViralHIV-1HumansJurkat CellsNuclear ProteinsStructure-Activity RelationshipTATA-Box Binding ProteinTranscription FactorsTumor Necrosis Factor-alphaAdenovirus E1A ProteinsDNA-Binding ProteinsNuclear ProteinsTATA-Box Binding ProteinTrans-ActivatorsTranscription FactorsTumor Necrosis Factor-alpha

Identifiers

PMID9032332
PMCPMC191285
OpenAlexW2102503945

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.